ABSTRACT Vacuolar protein sorting 9 (VPS9)-ankyrin-repeat protein (Varp) has recently been identified as an effector molecule for two small GTPases-Rab32 and Rab38-in the transport of a melanogenic enzyme tyrosinase-related protein 1 (Tyrp1) to melanosomes in melanocytes. Although Varp contains a Rab21-guanine nucleotide exchange factor (GEF) domain (i.e., VPS9 domain), since Rab21-GEF activity is not required for Tyrp1 transport, nothing is known about the physiological significance of the Rab21-GEF activity in melanocytes. Here we show by knockdown-rescue experiments that the Rab21-GEF activity of Varp, but not its Rab32/38 effector function, is required for forskolin-induced dendrite formation of cultured melanocytes. We found that Varp-deficient cells are unable to extend dendrites in response to forskolin stimulation and that reexpression of wild-type Varp or a Rab32/38-binding-deficient mutant Varp(Q509A/Y550A) in Varp-deficient cells completely restores their ability to form dendrites. By contrast, VPS9 mutants (D310A and Y350A) and a vesicleassociated membrane protein 7 (VAMP7)-binding-deficient mutant were unable to support forskolin-induced dendrite formation in Varp-deficient cells. These findings indicate that the Rab21-GEF activity and Rab32/38 binding activity of Varp are required for different melanocyte functions, that is, Rab21 activation by the VPS9 domain is required for dendrite formation, and the Rab32/38 effector function of the ankyrin repeat 1 domain is required for Tyrp1 transport to melanosomes, although VAMP7-binding ability is required for both functions.
INTRODUCTION
The small GTPase Rab is a conserved membrane-trafficking protein that regulates a variety of intracellular membrane-trafficking events in all eukaryotic cells (reviewed in Schwartz et al., 2007; Fukuda, 2008; Stenmark, 2009; Hutagalung and Novick, 2011) .
Rab is generally viewed as a molecular switch that functions by cycling between two nucleotide-bound states-a GDP-bound, inactive state and a GTP-bound, active state. Three key factors-a guanine nucleotide exchange factor (GEF), a Rab effector, and a GTPase-activating protein (GAP)-are generally believed to be required to exert the function of Rab protein in membrane trafficking (reviewed in Barr and Lambright, 2010) . The GTP-bound, active form of Rab, which is activated by a specific GEF, promotes membrane trafficking through interaction with a specific effector molecule and is then inactivated by a specific GAP. Although these three factors are usually encoded by different genes, recent evidence indicates that some factors play bifunctional roles in Rabmediated membrane trafficking (so-called Rab GEF/GAP cascades; reviewed in Stenmark, 2009) . A well-characterized example of a Rab GEF cascade is Sec2p, which is an effector for Ypt31/32p and a GEF for Sec4p in the budding yeast Saccharomyces cerevisiae (Ortiz et al., 2002) . Ypt31/32p recruits Sec2p and then activates Sec4p on the secretory vesicles in budding yeasts. Similarly, a class C VPS/HOPS complex, which is a GEF for Rab7, interacts with Rab5 shape to a dendritic shape ( Figure 1A , left half). Of interest, knockdown of endogenous Varp molecules in melanocytes completely suppressed the forskolin-induced dendrite formation (Figure 1 , A, right half, and B), indicating that Varp is involved in dendrite outgrowth of melanocytes, the same as in neurite outgrowth of hippocampal neurons (Burgo et al., 2009) . Similar Varp-dependent dendrite formation was also observed in cells treated with two other cAMP-elevating reagents, 8-bromo cAMP and 3-isobutyl-1-methylxanthine (IBMX; a phosphodiesterase inhibitor), although their dendrites were much shorter than the dendrites of forskolin-treated cells (Figure 1, C and D, respectively) . Because forskolin-induced dendrite formation in melan-a cells was clearly suppressed by H-89 (a protein kinase A [PKA] inhibitor) but was not suppressed by wortmannin (a phosphatidylinositol 3 [PI3]-kinase inhibitor) or by U0126 (a mitogen-activated protein kinase kinase [MEK] inhibitor), a cAMP-PKA pathway must be involved in forskolin-induced dendrite formation in melan-a cells (Figure 2 ).
We also tested the effect of overexpression of Varp on dendrite formation in melan-a cells and, as expected, found that overexpression of Varp in melan-a cells treated with IBMX, a weak inducer of dendrite formation ( Figure 1D ), promoted dendrite formation, although it did not induce dendrite formation in the absence of IBMX (i.e., in the presence of DMSO alone; Figure 1E ). Of interest, however, overexpression of Varp in melan-a cells treated with forskolin, a strong inducer of dendrite formation ( Figure 1B ), had no effect on dendrite formation (Supplemental Figure S1 , A, right half, and B). This discrepancy may be explained by the possibility that Varp activation is insufficient in IBMX-treated cells (i.e., exogenously expressed Varp is able to contribute to dendrite formation), whereas activation of Varp is saturated in forskolin-treated cells (i.e., exogenously expressed Varp is unable to contribute to dendrite formation).
The Rab21-GEF activity of Varp is essential for dendrite formation in melanocytes
Because Varp consists of at least four domains-a VPS9/Rab21-GEF domain (Zhang et al., 2006) , an ANKR1/Rab32/38 effector domain (Wang et al., 2008; Tamura et al., 2009 Tamura et al., , 2011 , a vesicle-associated membrane protein 7 (VAMP7)-interaction domain (VID; Burgo et al., 2009) , and an ANKR2 domain of unknown function (Figure 3 )-we next attempted to determine the role of the first three domains in forskolin-induced dendrite formation of melanocytes. We did so by performing knockdown-rescue experiments with mutants of the three domains of Varp, each of which lacks the function of only one of the three domains (summarized in Figure 3 ; Tamura et al., 2011) . In brief, the two VPS9 mutants-Varp(D310A) and Varp(Y350A)-that we used lack a conserved key residue of the VPS9 domain for GEF activity (Delprato et al., 2004; Delprato and Lambright, 2007; Tamura et al., 2011) ; the ANKR1 mutant Varp(Q509A/Y550A) completely lacks Rab32/38-binding activity (Tamura et al., 2011) ; and the Varp-ΔVID mutant lacks VAMP7-binding activity (Burgo et al., 2009 Figure 4A , second row from the top), neither VPS9 point mutant (D310A or Y350A) restored it at all (Figure 4 , A, bottom two rows, and B), strongly indicating that the Rab21-GEF activity of Varp is essential for forskolin-induced dendrite formation in melanocytes. These results are in sharp and is required for Rab5-to-Rab7 (i.e., early endosome-to-late endosome) conversion (Rink et al., 2005) . An example of a Rab GAP cascade is Gyp1p, which specifically interacts with Ypt32p and also functions as a GAP for Ypt1p (Rivera-Molina and Novick, 2009 ). Gyp1p regulates a transition from a Ypt1p-positive compartment to a Ypt32p-positive compartment in budding yeasts. More recently, several Tre-2/Bub2/Cdc16-domain-containing proteins/putative Rab-GAPs have been shown to bind nonsubstrate Rabs via a domain other than their GAP domain Kanno et al., 2010; reviewed in Fukuda, 2011) , suggesting that Rab GAP cascades may be more common in Rabmediated membrane-trafficking events.
Because the vacuolar protein sorting 9 (VPS9)-ankyrin-repeat protein (Varp; official name according to the National Center for Biotechnology Information, Ankrd27) molecule contains both a VPS9 domain (Carney et al., 2006) , which possesses Rab21-GEF activity (Zhang et al., 2006) , and a Rab32/38 effector domain (Wang et al., 2008; Tamura et al., 2009 Tamura et al., , 2011 , Varp may participate in a Rab GEF cascade. However, nothing is known about the functional relationship between Rab21 and Rab32/38 in membrane trafficking. The Rab32/38 effector function of Varp has recently been shown to be required for the transport of tyrosinase-related protein 1 (Tyrp1) to melanosomes in melanocytes, but there is no evidence that the Rab21-GEF activity of Varp is required for this process (Tamura et al., 2009 (Tamura et al., , 2011 . More recently, Varp and Rab21 have been shown to regulate neurite outgrowth of mouse hippocampal neurons and PC12 cells, but whether Rab32/38 is involved in this process has not been investigated (Burgo et al., 2009) . It would therefore be interesting to learn whether the VPS9 domain (i.e., the Rab21-GEF activity) and an ankyrin repeat 1 domain (ANKR1; i.e., the Rab32/38 effector activity) of Varp function independently or cooperatively.
In the present study, we used a knockdown-rescue approach combined with site-directed mutagenesis to investigate involvement of the Rab21-GEF activity and Rab32/38-binding activity of Varp in forskolin-induced dendrite formation of melanocytes. The results showed that a Rab32/38-binding-deficient mutant fully supported forskolin-induced dendrite formation of melanocytes but VPS9 mutants of Varp did not. We discuss the distinct mechanisms of Varp/Rab32/38-dependent Tyrp1 trafficking and Varp/Rab21-dependent dendrite formation in melanocytes based on our findings.
RESULTS

Varp is required for forskolin-induced dendrite formation in melanocytes
Varp was originally identified as a Rab21-GEF through its VPS9 domain (Zhang et al., 2006) , but recently it has been shown to function as a Rab32/38 effector in Tyrp1 transport in melanocytes (Tamura et al., 2009 (Tamura et al., , 2011 . The physiological significance of the Rab21-GEF activity of Varp in melanocytes, however, had not been determined. To do so, we focused on forskolin-induced dendrite outgrowth of melanocytes (Passeron et al., 2004) , because dendrite formation of melanocytes is believed to be essential for efficient transfer of melanosomes from melanocytes to neighboring keratinocytes (reviewed in Seiberg, 2001; Van Den Bossche et al., 2006) , and Varp has recently been shown to be involved in neurite outgrowth of mouse hippocampal neurons and PC12 cells (Burgo et al., 2009) . When cultured mouse melanocytes (i.e., melan-a cells) were treated for 20 h with 20 μM forskolin (or DMSO alone as a control), the cells extended several dendrites and dramatically changed their shape from a bipolar We reasoned that if the Rab21-GEF activity of Varp is actually essential for dendrite outgrowth, knockdown of Rab21 should result in a phenotype similar to that of the Varp-deficient melanocytes (i.e., a bipolar phenotype even in the presence of forskolin), and, as expected, knockdown of endogenous Rab21 molecules in melanocytes completely suppressed forskolin-induced dendrite formation ( Figure 5A , middle). This inhibition could not be attributable to an off-target effect of the Rab21 short hairpin RNA (shRNA), because contrast to our previous finding that both VPS9 mutants fully support Tyrp1 transport to melanosomes in Varp-deficient melanocytes (Tamura et al., 2011) .
it clearly restored forskolin-induced dendrite formation, the same as the wild-type Varp did ( Figure 6 , A, middle and bottom, and B). This result was quite unexpected, because we recently showed that neither the Varp SR (Q509A) nor the Varp SR (Y550A) mutant is able to support Tyrp1 transport to melanosomes in melanocytes (Tamura et al., 2011 ; see also Figure 6C , bottom, second from the right; Tyrp1 signals were almost absent in Varp SR (Q509A/Y550A)-expressing cells). Because the Rab32/38 effector function of Varp is highly unlikely to be required for forskolin-induced dendrite formation in melanocytes, we hypothesized that Rab32 and Rab38 themselves (i.e., ligands of Varp) are also unnecessary for this process. To test our hypothesis, we investigated the dendrite forming ability of Rab32/38-deficient melanocytes, that is, Rab32-knockdown melan-cht cells, which are genetically deficient in rab38 (Loftus et al., 2002; Wasmeier et al., 2006) . As shown in Figure 7 , A and B, melan-cht cells were able to form several dendrites in response to forskolin (bottom and next to bottom), despite the Rab32 knockdown. By contrast, knockdown of Varp in melan-cht cells was sufficient to inhibit forskolin-induced dendrite formation (Figure 7, C and D) , the same as knockdown of Varp in melan-a cells was. It should be noted, however, that Tyrp1 signals were clearly diminished and clustered around the perinucleus in Rab32/38-deficient melan-cht cells under the same experimental conditions (Supplemental Figure S5 , bottom), consistent with previous reports (Wasmeier et al., 2006; Tamura et al., 2011) .
VAMP7-binding activity of Varp is required for dendrite formation in melanocytes
We then investigated whether the VAMP7-binding activity of Varp is involved in the forskolin-induced dendrite formation in melanocytes by reexpressing Varp SR -ΔVID in Varp-deficient melanocytes. The results clearly showed that the Varp SR -ΔVID mutant did not restore forskolin-induced dendrite formation in Varp-deficient melanocytes (Figure 8, A and B) . In addition, knockdown of endogenous VAMP7 molecules in melanocytes caused complete suppression of forskolininduced dendrite formation, and reexpression of VAMP7 SR in VAMP7-deficient cells restored dendrite formation (Figure 8, C and D) . We therefore concluded that the interaction between Varp and VAMP7 is a process that is essential to dendrite outgrowth in melanocytes.
Rab21 and Rab32/38 are present in distinct membrane compartments in melanocytes
The results of the knockdown-rescue experiments described here clearly indicated that activation of Rab21 by Varp is required for reexpression of enhanced green fluorescent protein (EGFP)-tagged Rab21 SR (Supplemental Figure S2 ) in Rab21-deficient melanocytes clearly restored forskolin-induced dendrite formation ( Figure 5 , A, right, and B). Moreover, the results of active Rab21 pull-down assays performed with the Rab21-binding domain of APPL1 (Zhu et al., 2007) from melanocyte lysates indicated that Rab21 actually becomes activated 60 min after forskolin treatment (Supplemental Figure S3 ). These results allowed us to conclude that activation of Rab21 by the Varp VPS9 domain is required for forskolin-induced dendrite formation in melanocytes. Of interest, however, expression of a constitutive-active mutant Rab21(Q76L) or a constitutive-negative mutant Rab21(T31N) in normal melan-a cells had no effect on forskolin-induced dendrite formation (Supplemental Figure S4 ). Although we do not know the exact reason for their lack of effect, the level of expression of Rab21(Q76L)/(T31N) in melanocytes may be insufficient to function as a dominant-active/negative construct in comparison with the level of endogenous Rab21 protein. To investigate this possibility, siRNA-resistant forms of these Rab21 mutant proteins were expressed in Rab21-deficient cells. As shown in Figure  5C , reexpression of wild-type Rab21 SR and Rab21 SR (Q76L) clearly restored forskolin-induced dendrite formation, and the total dendrite length of the Rab21 SR (Q76L)-reexpressing cells appeared to be longer than that of the Rab21 SR -reexpressing cells, although the difference was not statistically significant under our experimental conditions. By contrast, reexpression of Rab21 SR (T31N) in Rab21-deficient cells did not restore forskolin-induced dendrite formation. To further highlight the difference between wild-type Rab21 and its constitutive-active mutant (Q76L), we investigated their effect on forskolin-induced dendrite formation in "Varp SR (D310A)-reexpressing Varp-deficient melan-a cells" (Rab21 should not be activated by Varp molecules under these conditions). As expected, only Rab21(Q76L) significantly promoted forskolin-induced dendrite formation ( Figure 5D ), and the wild-type Rab21 did not promote it, strongly indicating that activation of Rab21 by Varp is necessary for dendrite formation.
The Rab32/38 effector function of Varp is not required for dendrite formation in melanocytes Varp contains an N-terminal VPS9 domain (i.e., Rab21-GEF domain) and two ankyrin repeats-ANKR1 (i.e., Rab32/38 effector domain) and ANKR2-which are separated by a VID (VAMP7-interaction domain). The Rab21-GEF activity, Rab32/38-binding activity, VAMP7-binding activity, Tyrp1 transport activity, and dendrite formation activity of the wild-type and mutant Varp molecules are summarized at the right of each construct (+ or -). A detailed description of the two VPS9 mutants (D310A and Y350A), ANKR1 mutant (Q509A/Y550A), and ΔVID mutant lacking amino acid residues 641-707 is provided in Tamura et al. (2011) . SR and pSilencer-VAMP7 (right) and then stimulated with 20 μM forskolin (Fsk) for 20 h. Images of EGFP-expressing cells were captured at random, and the total length of their dendrites was measured as described in Materials and Methods. Typical images of EGFP-expressing cells (top) and corresponding bright-field images (bottom) are shown. Scale bars, 20 μm. Note that knockdown of endogenous VAMP7 molecules completely inhibited forskolin-induced dendrite formation in melanocytes, whereas reexpression of EGFP-VAMP7 SR in VAMP7-deficient melan-a cells completely restored forskolin-induced dendrite formation.
FIGURE 9: Rab21 and Rab32/38 are present in distinct membrane compartments in melanocytes. Immunoaffinity purification of Rab32-containing vesicles/organelles from crude membrane fractions of B16-F1 cells was performed by using anti-Rab32 IgG (lane 3) or control rabbit IgG (lane 2) as described in Materials and Methods. The Rab32-containing membrane compartment was analyzed by 10% SDS-PAGE, followed by immunoblotting with anti-Varp antibody (0.4 μg/ml), anti-tyrosinase antibody (0.3 μg/ml), anti-Rab32 antibody (1.5 μg/ml), anti-Rab38 antibody (0.9 μg/ml), anti-Rab21 antibody (0.2 μg/ml), anti-EEA1 antibody (1/1000 dilution), and anti-GM130 antibody (0.3 μg/ml). Note that Rab21 was not copurified with the Rab32-membrane compartment, which clearly includes Rab38, tyrosinase, and Varp but not EEA1 or GM130. Input means 1% volume of the crude membrane fractions used for immunoaffinity purification. The positions of the molecular mass markers (in kilodaltons) are shown on the left.
forskolin-induced dendrite formation in melanocytes and that the Rab32/38 effector function of Varp is not. We therefore hypothesized that Varp regulates dendrite outgrowth via a pathway that is independent of Rab32/38-mediated membrane trafficking-in other words, that the Rab32/38-containing membrane compartment and Rab21-containing membrane compartment are different. To test our hypothesis, we finally attempted to determine whether Rab21 is present in the Rab32/38-containing membrane compartment biochemically by performing a vesicle/organelle pull-down assay with specific antibodies. As expected, the Rab32-containing membrane compartment purified by the anti-Rab32-specific antibody did not contain either Rab21 or EEA1 (an early endosome marker), but it clearly contained Rab38 (which redundantly regulates trafficking of melanogenic enzymes, tyrosinase and Tyrp1, together with Rab32; Wasmeier et al., 2006) , tyrosinase (a cargo of Rab32/38-containing vesicles/organelles; Wasmeier et al., 2006) , and Varp (Rab32-binding protein; Tamura et al., 2009; Figure 9) . We also tried the reverse approach, but, unfortunately, the anti-Rab21 antibody we used was inappropriate for a vesicle/organelle pull-down assay (data not shown). To overcome this problem, we compared the subcellular localization of HA-Rab21 and FLAG-Rab32/38 by means of an immunofluorescence analysis of melan-a cells, and consistent with the results of the vesicle/organelle pull-down assay, no colocalization between HA-Rab21 and FLAG-Rab32/38 was observed (Supplemental Figure S6 ). cascade; Stenmark, 2009; Hutagalung and Novick, 2011) . As an example, Ypt31/32p recruits Sec2p to secretory vesicles, and then Sec2p activates Sec4p on secretory vesicles in budding yeasts (Ortiz et al., 2002) . Rabin8, a mammalian Sec2 homologue that acts as a Rab8-GEF (Hattula et al., 2002) , also functions as a Rab11A effector during epithelial polarization (Bryant et al., 2010) . It should be noted that Rab11 binding to Rabin8 promotes Rab8-GEF activity in vitro (Knödler et al., 2010) . Our finding that the Rab21-GEF activity of the VPS9 domain and the Rab32/38-binding activity of the ANKR1 domain of Varp function independently in melanocytes is in sharp contrast to the previous finding about other Rab-binding GEFs. To our knowledge, this study is the first to demonstrate that two distinct Rab signaling domains of Varp (i.e., the Rab21-GEF domain and the Rab32/38 effector domain) independently regulate different membrane-trafficking pathways within a single cell, although we cannot completely rule out the possibility that Rab21-GEF Varp constitutes a Rab-GEF cascade together with an unidentified Rab other than Rab32/38 during dendrite formation in melanocytes.
What is the regulatory mechanism of the activation of Rab21 by Varp and the Rab32/38 effector function of Varp in melanocytes? These are open questions, but we believe that the Rab21-GEF activity and Rab32/38-binding activity of Varp are independently regulated in melanocytes, because the VPS9 point mutants and Rab32/38-binding-deficient mutant of Varp were found to be fully capable of mediating the Tyrp1 trafficking to melanosomes and forskolin-induced dendrite formation, respectively, in Varp-deficient melanocytes (Tamura et al., 2011 and this study) . Because the Rab21-GEF activity of Varp is required for staurosporine-induced neurite outgrowth in PC12 cells (Burgo et al., 2009 ) and forskolininduced dendrite formation in melan-a cells (this study), and both staurosporine and forskolin may modulate protein kinase (e.g., PKC and PKA) cascades, phosphorylation of Varp might be involved in regulation of the Rab21-GEF activity of Varp. Actually, the forskolininduced dendrite formation was clearly suppressed by the PKA inhibitor H-89 (Figure 2, A and B) , indicating that PKA is involved in this process. Further work will be necessary to determine the mechanism by which PKA stimulates the Rab21-GEF activity at the molecular level.
In conclusion, the results of the knockdown-rescue experiments in this study showed that activation of Rab21 by the Varp VPS9 domain is required for forskolin-induced dendrite formation and that the Rab32/38 effector function of Varp is not. By contrast, the Rab32/38 effector function of Varp, but not its Rab21-GEF activity, has been shown to be required for Tyrp1 trafficking to melanosomes (Tamura et al., 2011) . Because these findings indicated the presence of a novel mechanism in which two Rab signaling domains in a single Varp molecule, that is, the Rab21-GEF domain and the Rab32/38 effector domain, regulate different membrane-trafficking pathways, that is, dendrite formation and Tyrp1 transport, respectively, Varp contributes to efficient skin darkening by coupling these two distinct processes. Because Varp is expressed in a variety of mouse tissues and cell lines (Zhang et al., 2006) , it would be interesting to determine whether the function of the two domains of Varp is also regulated independently in other cells besides melanocytes.
MATERIALS AND METHODS Materials
Anti-Tyrp1 mouse monoclonal antibody (Ta99) was obtained from ID Labs (London, Canada). Anti-actin goat polyclonal antibody and anti-actin mouse monoclonal antibody were from Santa Cruz Biotechnology (Santa Cruz, CA) and Applied Biological Materials (Richmond, Canada), respectively. Anti-EEA1 mouse monoclonal
DISCUSSION
We previously showed that Varp together with Rab32/38 regulates Tyrp1 trafficking to melanosomes in melanocytes and that activation of Rab21 by Varp (or Rab21 itself) is not needed for this process to occur (Tamura et al., 2009 (Tamura et al., , 2011 . In the present study, we discovered a novel function of Varp in melanocytes, that is, regulation of forskolin-stimulated dendrite formation (Figure 1 ), a function that is believed to be required for efficient melanosome transfer from melanocytes to neighboring keratinocytes. However, the results we obtained were the opposite of the results obtained when we investigated the role of Varp in Tyrp1 trafficking to melanosomes. Both the Rab21-GEF activity of Varp and its substrate Rab21 are required for forskolin-induced dendrite formation (Figures 4 and 5) , whereas the Rab32/38-binding activity of Varp and its ligand Rab32/38 are not (Figures 6 and 7) . Furthermore, Rab21-containing vesicles and Rab32/38-containing vesicles are distributed differently in melanocytes ( Figure 9 and Supplemental Figure S6 ). We therefore concluded that Varp regulates two independent membrane trafficking pathways in the same melanocyte-that is, the membrane-trafficking pathway involved in dendrite formation and the membranetrafficking pathway involved in Tyrp1 trafficking to melanosomesvia two distinct domains-its VPS9/Rab21-GEF domain and its ANKR1/Rab32/38 effector domain, respectively-although the VID domain (and its ligand VAMP7) is required for both pathways ( Figure  8 ; Tamura et al., 2011) . Possible mechanisms by which Varp regulates two distinct membrane trafficking pathways are illustrated in Supplemental Figure S7 .
How does Rab21 promote dendrite formation in melanocytes? We believe that dendrite formation in melanocytes requires the occurrence of at least two different processes: cytoskeletal rearrangement (e.g., reorganization of the actin cytoskeleton) and supply of new membranes/proteins to elongate dendrites (e.g., transport of endosome-derived vesicles to the tip of dendrites, as proposed for the role of endosomal trafficking in neurite outgrowth in neurons; reviewed in Sann et al., 2009) . Because Rab21 (and also VAMP7) is a membrane-trafficking protein and has been shown to be involved in endosomal trafficking (Simpson et al., 2004; Pellinen et al., 2006; Zhang et al., 2006; Chaineau et al., 2009) , Rab21 is likely to be involved in the process of supplying new membranes/proteins to elongate dendrites rather than in the process of cytoskeletal rearrangement. Furthermore, since overexpression of Rab21(Q76L) alone (i.e., activation of Rab21) was unable to induce dendrite formation in melanocytes ( Figure 5C ), additional factors, for example, other types of small GTPases, that induce cytoskeletal rearrangement are also required for dendrite formation in melanocytes. Actually, our preliminary data showed that overexpression of a dominantnegative form of Rac1 strongly inhibited forskolin-induced dendrite formation in melan-a cells (A. Yatsu, N. Ohbayashi, and M. Fukuda, unpublished data) . We therefore speculate that forskolin (presumably PKA) activates both Rab21-dependent endosomal trafficking, which contributes to membrane addition for dendrite outgrowth, and cytoskeletal rearrangement, which is presumably mediated by other types of small GTPases (e.g., Rac1). Further extensive research will be necessary to elucidate the precise downstream mechanism of Rab21 and the mechanism that regulates cytoskeletal rearrangement during dendrite formation in melanocytes.
Thus far, several Rab-GEFs, including Sec2p and Rabin8, have been shown to bind a nonsubstrate Rab protein via a domain other than a GEF domain (Ortiz et al., 2002; Knödler et al., 2010) . These Rab GEFs have been reported to play bifunctional roles, that is, a Rab-GEF role and a Rab effector role, in the "same" membranetrafficking pathway by sequential mechanisms (i.e., a Rab GEF antibody and anti-GM130 mouse monoclonal antibody were from Cell Signaling Technology (Danvers, MA) and BD Biosciences (San Jose, CA), respectively. Anti-FLAG tag rabbit polyclonal antibody and anti-HA tag mouse monoclonal antibody were from SigmaAldrich (St. Louis, MO) and Roche Molecular Biochemicals (Mannheim, Germany), respectively. Anti-GFP (green fluorescent protein) rabbit polyclonal antibody, horseradish peroxidase (HRP)-conjugated anti-GFP antibody, and HRP-conjugated red fluorescent protein antibody were from MBL (Nagoya, Japan). HRP-conjugated anti-glutathione S-transferase (GST) antibody was from Santa Cruz Biotechnology. Alexa 488/594-conjugated anti-mouse immunoglobulin (IgG) goat antibody was from Invitrogen (Carlsbad, CA). Anti-Varp rabbit polyclonal antibody, anti-Rab21 rabbit polyclonal antibody, anti-Rab32 rabbit polyclonal antibody, and anti-Rab38 rabbit polyclonal antibody were prepared as described previously (Tamura et al., 2009 (Tamura et al., , 2011 . Anti-tyrosinase rabbit polyclonal antibody was raised against a peptide corresponding to the C-terminal sequence (amino acid residues 520-533) of mouse tyrosinase (Jiménez et al., 1991; Beaumont et al., 2011) and then affinity-purified essentially as described previously . All other reagents used in this study were analytical grade or the highest grade commercially available.
Plasmid constructions
Mouse monomeric Strawberry (mStr)-tagged Varp expression plasmids carrying a D310A, Y350A, or Q509A/Y550A mutation or carrying a deletion of amino acid residues 641-707 (named ΔVID; Burgo et al., 2009) were prepared as described previously (Tamura et al., 2011) . pSilencer-Varp, pSilencer-VAMP7, pSilencer-Rab21, pmStr-C1-Varp SR (siRNA resistant), pEF-FLAG-Rab32/38, pEGFP-C1-Rab21(Q76L), pEGFP-C1-Rab21(T31N), and pEGFP-C1-VAMP7 SR were also prepared as described previously (Tamura et al., 2009 (Tamura et al., , 2011 . pEF-HA-Rab21 was prepared by subcloning the Rab21 fragment into the pEF-HA expression vector (Fukuda, 2002) . The knockdown efficiency of each pSilencer vector and siRNA resistance of Varp SR (or VAMP7 SR ) have been described elsewhere (Tamura et al., 2009 (Tamura et al., , 2011 . cDNA encoding the Rab21-binding site of mouse APPL1 (adaptor protein containing PH domain, PTB domain, and leucine zipper motif; amino acids 5-377; named APPL1-N; Zhu et al., 2007) was amplified by conventional PCR techniques and subcloned into the pEF-T7-GST vector modified from pEF-BOS . All Varp mutant proteins were strongly expressed in the melanocytes, the same as the wild-type protein was (Tamura et al., 2011; Supplemental Figure S1D ), and their expression in melan-a cells alone had no effect on forskolin-induced dendrite formation (Supplemental Figure S1C) . The siRNA against Rab32 (Oligo 32-1) was synthesized as described previously (Wasmeier et al., 2006) . pEGFP-C1-Rab21 SR , pEGFP-C1-Rab21 SR (Q76L), and pEGFP-C1-Rab21 SR (T31N) were produced by using the same method described previously (Tamura et al., 2011) using the following mutagenic oligonucleotides (substituted nucleotides are shown in italics): 5′-CCCAATCTATTATCGGGACTCTAACGGAGC-3′ (Rab21 SR-5′ primer, sense) and 5′-CCTCCGTTAGAGTCCCGATAATAGATT-GGG-3′ (Rab21 SR-3′ primer, antisense). The siRNA resistance of Rab21 SR was checked by coexpressing Rab21 shRNA and pEGFPRab21 SR in COS-7 cells (Supplemental Figure S2 ).
Forskolin-induced dendrite formation in melanocytes
The immortal mouse melanocyte cell line melan-a, derived from a black mouse, and melan-cht, derived from a chocolate mouse, both generous gifts of Dorothy C. Bennett (St George's Hospital Medical School, London, United Kingdom), were cultured on glass-bottom dishes (35-mm dish; MatTek, Ashland, MA; Bennett et al., 1987; Kuroda et al., 2003) . Cotransfection of pmStr-C1-Varp SR and pSilencer-Varp (or control pSilencer alone), pEGFP-C1-VAMP7 SR and pSilencer-VAMP7 (or pSilencer), or pEGFP-C1-Rab21 SR and pSilencer-Rab21 (or pSilencer) was achieved by using FuGENE 6 (Roche Molecular Biochemicals) according to the manufacturer's instructions. Cells were treated with 20 μM forskolin (Sigma-Aldrich), 10 μM IBMX (Nacalai Tesque, Kyoto, Japan), 100 μM 8-bromo cAMP (Sigma-Aldrich), or DMSO alone (control) 1 d after transfection. Twenty hours after the drug treatment, the cells were fixed in 4% paraformaldehyde and examined for fluorescence with a confocal fluorescence microscope (FluoView; Olympus, Tokyo, Japan). The images of the EGFP-expressing cells (for VAMP7 and Rab21) and mStr-expressing cells (for Varp) were captured at random (n > 30 from three independent dishes) with the confocal microscope, and the total length of their dendrites was measured with ImageJ software (version 1.43u; National Institutes of Health, Bethesda, MD). Length of each dendrite was measured from the edge of the cell body to the tip of dendrites, and total dendrite length means the sum of each dendrite length (see Figure 1A , middle left).
Immunofluorescence analysis
Melan-a cells (or melan-cht cells) were cotransfected with pmStr-C1-Varp SR (or pmStr-C1-Varp SR (Q509A/Y550A)) and pSilencer-Varp (or control pSilencer alone) as described. Two days after transfection, the cells were fixed in 4% paraformaldehyde, permeabilized with 0.3% Triton X-100, stained with anti-Tyrp1 mouse monoclonal antibody (1/100 dilution), and then visualized with anti-mouse Alexa Fluor 488 IgG and examined for fluorescence with a confocal fluorescence microscope as described. The images of the cells were processed with Adobe Photoshop software (CS4; San Jose, CA).
Active GTP-Rab21 pull-down assays GTP-Rab21 pull-down assays were performed essentially as described previously (Itoh and Fukuda, 2006) . In brief, pEF-T7-GST, pEF-T7-GST-APPL1-N, pEGFP-Rab21(T31N), or pEGFP-Rab21(Q76L) was transfected into COS-7 cells with Lipofectamine-LTX-PLUS (Invitrogen) according to the manufacturer's instructions. Two days after transfection, the cells were harvested and lysed with a lysis buffer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES]-KOH at pH 7.2, 150 mM NaCl, 1 mM MgCl 2 , and 1% Triton X-100) containing appropriate protease inhibitors. GlutathioneSepharose beads (GE Healthcare, Little Chalfont, United Kingdom) coupled with T7-GST-APPL1-N (or T7-GST alone) were incubated for 1 h with the COS-7 cell lysates containing EGFP-Rab21(T31N) and EGFP-Rab21(Q76L) in the presence of 1 mM GDP and 0.5 mM GTPγS, respectively. After washing the beads three times, proteins bound to the beads were subjected to 10% SDS-PAGE, followed by immunoblotting with HRP-conjugated anti-GFP antibody and HRPconjugated anti-GST antibody. pEF-FLAG-Rab21 was transfected into B16-F1 cells with Lipofectamine-LTX-PLUS. One day after transfection, the cells were treated with 20 μM forskolin for 30-120 min, and they were then harvested and lysed with the lysis buffer as described. Glutathione-Sepharose beads coupled with T7-GST-APPL1-N were incubated for 1 h with the B16-F1 cell lysates without further addition of guanine nucleotides. Active GTP-Rab21 was detected in a manner similar to that described.
Immunoaffinity purification of a Rab32-containing membrane compartment
Immunoaffinity purification of a Rab32-containing membrane compartment with anti-Rab32 IgG-conjugated magnetic beads was
